tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Driscoll, 280 are a BUY (90.03%), 29 are a HOLD (9.32%), 2 are a SELL (0.64%).
Analyst Robert Driscoll, currently employed at WEDBUSH, carries an average stock price target met ratio of 47.92% that have a potential upside of 56.15% achieved within 268 days.
Robert Driscoll’s has documented 584 price targets and ratings displayed on 44 stocks. The coverage is on Healthcare, Energy sectors.
Most recent stock forecast was given on RVMD, Revolution Medicines at 02-Jul-2026.
Analyst best performing recommendations are on RVMD (REVOLUTION MEDICINES).
The best stock recommendation documented was for REPL (REPLIMUNE GROUP) at 4/13/2026. The price target of $2 was fulfilled within 1 day with a profit of $2.76 (57.98%) receiving and performance score of 579.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Sep-2020
$5
$0.42 (9.17%)
$5
7 months 29 days ago
(14-Nov-2025)
4/14 (28.57%)
$0.48 (10.62%)
136
Buy Since 05-Nov-2021
$5
$0.42 (9.17%)
$5
1 years 3 months 12 days ago
(31-Mar-2025)
2/10 (20%)
$1.51 (43.27%)
256
Buy Since 17-Dec-2020
$5
$0.42 (9.17%)
$5
1 years 5 months 22 days ago
(21-Jan-2025)
0/18 (0%)
$1.79 (55.76%)
Buy Since 02-Feb-2022
$5
$0.71 (16.55%)
$4
4 years 5 months 12 days ago
(02-Feb-2022)
1/2 (50%)
$2.11 (73.01%)
980
Buy Since 05-Mar-2020
$7
5 years 16 days ago
(28-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
Which stock is Robert Driscoll is most bullish on?
Which stock is Robert Driscoll is most reserved on?
What Year was the first public recommendation made by Robert Driscoll?
